New laboratory boosts high-potency drug development

US-based Continuus Pharmaceuticals has opened a new laboratory space and new technology to help the development of high-potency drugs.

The new lab and technology are the latest developments in Continuus’ ongoing expansion, coming six months after receiving a US$69.3 million US government contract for the domestic production of medicines.

“Our new lab space, located one mile from our current manufacturing site and corporate headquarters, will help Continuus advance our mission for on-demand delivery of affordable, high-quality, vital medicines to patients in need of therapeutic solutions, and will also help facilitate collaborations with innovator companies that are developing high-potency drugs,” said Salvatore Mascia, Founder and Chief Executive officer of Continuus.

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free